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The laboratorymouse shares themajority of its protein-coding geneswithhumans,making it the premiermodel organism
in biomedical research, yet the two mammals differ in significant ways. To gain greater insights into both shared and
species-specific transcriptional and cellular regulatory programs in the mouse, the Mouse ENCODE Consortium has
mapped transcription, DNase I hypersensitivity, transcription factor binding, chromatin modifications and replication
domains throughout the mouse genome in diverse cell and tissue types. By comparing with the human genome, we not
only confirm substantial conservation in the newly annotated potential functional sequences, but also find a large degree
of divergence of sequences involved in transcriptional regulation, chromatin state and higher order chromatin organi-
zation. Our results illuminate the wide range of evolutionary forces acting on genes and their regulatory regions, and
provide a general resource for research into mammalian biology and mechanisms of human diseases.
Despite the widespread use of mouse models in biomedical research1,
the genetic and genomic differences betweenmice and humans remain
to be fully characterized. At the sequence level, the two species have
diverged substantially: approximately onehalf of humangenomicDNA
can be aligned to mouse genomic DNA, and only a small fraction (3–
8%) is estimated to be under purifying selection across mammals2. At
the cellular level, a systematic comparison is still lacking. Recent studies
have revealed divergent DNA binding patterns for a limited number of
transcription factors across multiple related mammals3–8, suggesting
potentially wide-ranging differences in cellular functions and regula-
tory mechanisms9,10. To fully understand how DNA sequences con-
tribute to the uniquemolecular and cellular traits inmouse, it is crucial
to have a comprehensive catalogue of the genes and non-coding func-
tional sequences in the mouse genome.
Advances in DNA sequencing technologies have led to the develop-
mentofRNA-seq (RNAsequencing),DNase-seq (DNase Ihypersensitive
sites sequencing),ChIP-seq (chromatin immunoprecipitation followed
byDNAsequencing), andothermethods that allow rapid andgenome-
wide analysis of transcription, replication, chromatin accessibility, chro-
matin modifications and transcription factor binding in cells11. Using
these large-scale approaches, the ENCODE consortium has produced
a catalogue of potential functional elements in the human genome12.
Notably, 62% of the human genome is transcribed in one or more cell
types13, and 20% of humanDNA is associated with biochemical signa-
tures typical of functional elements, including transcription factorbind-
ing, chromatin modification and DNase hypersensitivity. The results
support the notion that nucleotides outside themammalian-conserved
genomic regions could contribute to species-specific traits6,12,14.
We have applied the same high-throughput approaches to over 100
mouse cell types and tissues15, producing a coordinated group of data
sets for annotating the mouse genome. Integrative analyses of these
data sets uncoveredwidespread transcriptional activities, dynamic gene
expressionandchromatinmodificationpatterns, abundant cis-regulatory
elements, and remarkably stable chromosome domains in the mouse
genome.Thegenerationof thesedata sets also allowedanunprecedented
level of comparisonof genomic features ofmouseandhuman.Described
in the current manuscript and companion works, these comparisons
revealed both conserved sequence features andwidespread divergence
in transcription and regulation. Some of the key findings are:
. Although much conservation exists, the expression profiles of many
mouse genes involved in distinct biological pathways show consider-
able divergence from their human orthologues.
. A large portion of the cis-regulatory landscape has diverged between
mouse andhuman, although themagnitudeof regulatoryDNAdiver-
gence varies widely between different classes of elements active in
different tissue contexts.
. Mouse and human transcription factor networks are substantially
more conserved than cis-regulatory DNA.
. Species-specific candidate regulatory sequences are significantly
enriched for particular classes of repetitive DNA elements.
. Chromatin state landscape in a cell lineage is relatively stable in both
human and mouse.
. Chromatin domains, interrogated through genome-wide analysis of
DNA replication timing, are developmentally stable and evolution-
arily conserved.
Overview of data production and initial processing
To annotate potential functional sequences in the mouse genome, we
usedChIP-seq, RNA-seq andDNase-seq to profile transcription factor
binding, chromatinmodification, transcriptome and chromatin acces-
sibility in a collection of 123mouse cell types and primary tissues (Fig. 1a,
SupplementaryTables 1–3).Additionally, to interrogate large-scale chro-
matin organization across different cell types, we also used amicroarray-
based technique togenerate replication-timingprofiles in18mouse tissues
and cell types (SupplementaryTable 3)16. Altogether,weproduced over
1,000 data sets. The list of the data sets and all the supporting material
for thismanuscript are also available at website http://mouseencode.org.
Belowwebriefly outline the experimental approach and initial datapro-
cessing for each class of sequence features.
RNA transcriptome
To comprehensively identify the genic regions that produce transcripts
in themouse genome, we performedRNA-seq experiments in 69 differ-
entmouse tissues and cell typeswith twobiological replicates each (Sup-
plementaryTable 3, Supplementary Information) anduncovered436,410
contigs (Supplementary Table 4). Confirming previous reports13,17,18
and similar to the human genome, the mouse genome is pervasively
transcribed (Fig. 1b), with 46% capable of producing polyadenylated
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messenger RNAs (mRNA). By comparison, 39% of the human gen-
ome is devoted to making mRNAs. In both species, the vast majority
(87–93%) of exonic nucleotideswere detected as transcribed, confirm-
ing the sensitivity of the approach. However, a higher percentage of
intronic sequences were detected as transcribed in themouse, and this
might be owing to a greater sequencing depth and broader spectrumof
biological samples analysed in mouse (Fig. 1b).
Candidate cis-regulatory sequences
To identify potential cis-regulatory regions in the mouse genome, we
used three complementary approaches that involvedmapping of chro-
matin accessibility, specific transcription factor occupancy sites and
histonemodification patterns. All of these approaches have previously
been shown to uncover cis regulatory elements with high accuracy and
sensitivity19,20.
BymappingDNase I hypersensitive sites (DHSs) in55mouse cell and
tissue types21, we identified a combined total of ,1.5 million distinct
DHSs at a false discovery rate (FDR) of 1% (Supplementary Table 5)22.
Genomic footprinting analysis in a subset (25) of these cell types fur-
ther delineated 8.9 million distinct transcription factor footprints.
De novo derivation of a cis-regulatory lexicon from mouse transcrip-
tion factor footprints revealed a recognition repertoire nearly identical
with that of the human, including both known and novel recognition
motifs25.
We used ChIP-seq to determine the binding sites for a total of 37
transcription factors in various subsets of 33 cell/tissue types. Of these
37 transcription factors, 24were also extensivelymapped in themurine
andhumanerythroid cellmodels (MELandK562) andB-lymphoid cell
lines (CH12 and GM12878)23. In total we defined 2,107,950 discrete
ChIP-seqpeaks, representing differential cell/tissue occupancy patterns
of 280,396 distinct transcription factor binding sites (Supplementary
Methods and Supplementary Table 6).
We also performed ChIP-seq for as many as nine histone H3mod-
ifications (H3K4me1, H3K4me2, H3K4me3, H3K9me3, H3K27ac,
H3K27me3,H3K36me3,H3K79me2andH3K79me3) inup to23mouse
tissues and cell types permark.We applied a supervisedmachine learn-
ing technique, random-forest based enhancerprediction fromchromatin
state (RFECS), to three histone modifications (H3K4me1, H3K4me3
andH3K27ac)24, identifying a total of 82,853 candidate promoters and
291,200 candidate enhancers in the mouse genome (Supplementary
Tables 7 and 8). To functionally validate the predictions, we randomly
selected 76 candidate promoter elements (average size 1,000 bp, Sup-
plementary Table 9) and 183 candidate enhancer elements (average
size1,000 bp, SupplementaryTable10). For candidatepromoterelements,
we cloned these previously unannotated sequences into reporter con-
structs, and performed luciferase reporter assays via transient transfec-
tion in pertinentmouse cell lines . For candidate enhancer elements,we
performed functional validation assayusing a high throughputmethod
(see SupplementaryMethods). Overall, 66/76 (87%) candidate promo-
ters and 129/183 (70.5%) candidate enhancers showed significant activity
in these assays, compared to 2/30 randomly selected negative controls
(Supplementary Fig. 1c).
Collectively, our studies assignedpotential regulatory function to12.6%
of the mouse genome (Fig. 1c).
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Figure 1 | Overview of the mouse ENCODE data sets. a, A genome browser
snapshot shows the primary data and annotated sequence features in themouse
CH12 cells (Methods). b, Chart shows that much of the human and mouse
genomes is transcribed in one or more cell and tissue samples. c, A bar chart
shows the percentages of the mouse genome annotated as various types of
cis-regulatory elements (Methods). DHS, DNase hypersensitive sites; TF,
transcription factor. d, Pie charts show the fraction of the entire genome that is
covered by each of the seven states in the mouse embryonic stem cells (mESC)
and adult heart. e, Charts showing the number of replication timing (RT)
boundaries in specific mouse and human cell types, and the total number of
boundaries from all cell types combined. ESC, embryonic stem cell; endomeso,
endomesoderm; NPC, neural precursor; GM06990, B lymphocyte; HeLa-S3,
cervical carcinoma; IMR90, fetal lung fibroblast; EPL, early primitive
ectoderm-like cell; EBM6/EpiSC, epiblast stem cell; piPSC, partially induced
pluripotent stem cell; MEF, mouse embryonic fibroblast; MEL, murine
erythroleukemia; CH12, B-cell lymphoma.
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Transcription factor networks
Weexplored the transcription factor networks and combinatorial tran-
scription factor bindingpatterns in themouse samples in twocompanion
papers, and compared these networks to regulatory circuitry models
generated for the human genome23,25. Fromgenomic footprints, we con-
structed transcription-factor-to-transcription-factor cross-regulatory
network in each of 25 cell/tissue types for a total of,500 transcription
factors with known recognition sequences. Analyses of these networks
revealed regulatory relationships between transcription factor genes that
are strongly preserved in human and mouse, in spite of the extensive
plasticity of the cis-regulatory landscape (detailed below).Whereas only
22%of transcription factor footprints are conserved, nearly 50%of cross-
regulatory connections between mouse transcription factors are con-
served inhuman through the innovationofnovel binding sites.Moreover,
analysis of networkmotifs shows that larger-scale architectural features of
mouse andhuman transcription factor networks are strikingly similar25.
Chromatin states
We produced integrative maps of chromatin states in 15 mouse tissue
and cell types and six human cell lines (SupplementaryTable 11), using
a hiddenMarkovmodel (chromHMM)26,27 that allowed us to segment
the genome in each cell type into seven distinct combination of chro-
matin modification marks (or chromatin states). One state is charac-
terized by the absence of any chromatin marks, while every other state
features either predominantly onemodification or a combination of two
modifications (Extended Data Table 1, Supplementary Information).
Theportion of the genome in each chromatin state variedwith cell type
(Fig. 1d, Supplementary Fig. 2). Similar proportions of the genome are
found in the active states in each cell type, for both mouse and human.
Interestingly, excluding the ‘unmarked’ state, the fractionof eachgenome
that is in theH3K27me3-dominated, transcriptionally repressed state is
themost variable, suggestingaprofoundrole of transcriptional repression
in shaping the cis-regulatory landscape duringmammalian development.
Replication domains
Replication-timing, the temporal order inwhichmegabase-sized geno-
mic regions replicate during S-phase, is linked to the spatial organization
of chromatin in the nucleus28–31, serving as a useful proxy for tracking
differences in genome architecture between cell types32,33. Since different
types of chromatin are assembled at different times during the S phase34,
changes in replication timingduringdifferentiation could elicit changes
in chromatin structure across large domains. We obtained 36 mouse
and 31 human replication-timing profiles covering 11 and 9 distinct
stagesofdevelopment, respectively (SupplementaryTable12).Wedefined
‘replication boundaries’ as the sites where replication profiles change
slope fromsynchronously replicating segments (discussed later).A total
of 64,535 and 50,194 boundaries identified across allmouse and human
data sets, respectively, weremapped to 4,322 and 4,675 positions, with
each cell type displaying replication-timing transitions at 50–80% of
these positions (Fig. 1e).
Annotation of orthologous coding and non-coding genes
To facilitate a systematic comparison of the transcriptome, cis-regulatory
elements and chromatin landscape between the human and mouse
genomes, we built a high-quality set of human–mouse orthologues of
protein coding and non-coding genes35. The list of protein-coding orth-
ologues, basedonphylogenetic reconstruction, contains a total of 15,736
one-to-one and a smaller set of one-to-many andmany-to-many ortho-
logue pairs (Supplementary Tables 13–15). We also inferred ortholo-
gous relationships among short non-codingRNAgenes using a similar
phylogenetic approach.Weestablishedone-to-onehuman–mouseorth-
ologues for 151,257 internal exon pairs (Supplementary Table 16) and
204,887 intronpairs (SupplementaryTable17), andpredicted2,717 (3,446)
novel human (respectively, mouse) exons (Supplementary Table 18).
Additionally, we mapped the 17,547 human long non-coding RNA
(lncRNA) transcripts annotated inGencodev10onto themouse genome.
We found 2,327 (13.26%) human lncRNA transcripts (corresponding
to 1,679, or 15.48%, of the lncRNAgenes) homologous to 5,067putative
mouse transcripts (corresponding to 3,887putativegenes) (Supplementary
Fig. 3, SupplementaryTable 19).Consistentwithprevious observations,
only a small fractionof lncRNAsare constrainedat theprimary sequence
level, with rapid evolutionary turnover36. Other comparisons of human
andmouse transcriptomes, covering areas including pre-mRNA splic-
ing, antisense and intergenicRNA transcription, are detailed in an asso-
ciated paper37.
Divergent and conserved gene expression patterns
Previous studies have revealed remarkable examples of species-specific
gene expression patterns that underlie phenotypic changes during
evolution38–42. In these cases changes inexpressionof a single genebetween
closely related species led toadaptive changes.However, it is not clearhow
extensive the changes in expression patterns are betweenmoredistantly
related species, suchasmouse andhuman,with some studies emphasiz-
ing similarities in transcriptome patterns of orthologous tissues43–45 and
others emphasizing substantial interspecies differences46. Our initial
analyses revealed that gene expression patterns tended to clustermore
by species rather than by tissue (Fig. 2a). To resolve the sets of genes
contributing to different components in the clustering, we employed
variancedecomposition (seeMethods) to estimate, for eachorthologous
human–mouse gene pair, the proportion of the variance in expression
that is contributedby tissue andby species (Fig. 2b).This analysis revealed
the setsof geneswhose expressionvariesmoreacross tissues thanbetween
species, and those whose expression varies more between species than
across tissues.As expected, the clusteringof theRNA-seq samples is dom-
inated either by species or tissues, depending on the gene set employed
(Extended Data Fig. 1a, b). Furthermore, removal of the,4,800 genes
thatdrive the species-specific clustering (see ref. 47, SupplementaryFig. 1d
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Figure 2 | Comparative analysis of the gene expression programs in human
and mouse samples. a, Principal component analysis (PCA) was performed
for RNA-seq data for 10 human and mouse matching tissues. The expression
values are normalized across the entire data set. Solid squares denote human
tissues. Open squares denote mouse tissues. Each category of tissue is
represented by a different colour. b, Gene expression variance decomposition
(see Methods) estimates the relative contribution of tissue and species to the
observed variance in gene expression for each orthologous human–mouse gene
pair. Green dots indicate genes with higher between-tissue contribution and
red dots genes with higher between-species contributions. c, Neighbourhood
analysis of conserved co-expression (NACC) in human and mouse samples.
The distribution ofNACC scores for each gene is shown.d, A scatter plot shows
the average of NACC score over the set of genes in each functional gene
ontology category. Highlighted are those biological processes that tend to be
more conserved between human andmouse and those processes that have been
less conserved (see Supplementary Table 21 for list of genes).
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therein) or normalizationmethods that reduce the species effects reveal
tissue-specific patternsof expression in the same samples (ExtendedData
Fig. 1c). Categorizing orthologous gene pairs into these groups should
enablemore informative translation of research results betweenmouse
and human. In particular, for gene pairs whose variance in expression
is largest between tissues (and less between species), mouse should be a
particularly informative model for human biology. In contrast, inter-
pretationof studies involving geneswhose variance in expression is larger
between species needs to take into account the species variation. The
relative contributions of species-specific and tissue-specific factors to
each gene’s expression are further explored in two associated papers37,47.
To further identify genes with conserved expression patterns and
those that have diverged between humans and mice, we developed a
novel method, referred to as neighbourhood analysis of conserved co-
expression (NACC), to compare the transcriptional programs of orth-
ologous genes in away that did not require preciselymatched cell lines,
tissues or developmental stages, as long as a sufficiently diverse panel of
samples is used in each species (Supplementary Methods). Observing
that the orthologues of most sets of co-expressed genes in one species
remained significantly correlated across samples in the other species,
we use themean of these small correlated sets of orthologous genes as a
reference expressionpattern in theother species.We computeEuclidean
distance to the reference pattern in the multi-dimensional tissue/gene
expression space as a relative measure of conservation of expression of
each gene. Specifically, for each human gene (the test gene), we defined
themost similarly expressed set of genes (n5 20) across all the human
samples as that gene’s co-expressionneighbourhood.We thenquantify
the average distance between the transcript levels of the mouse ortho-
logue of the test gene and the transcript levels of eachmouse orthologue
of the neighbourhood genes across the mouse samples. We then invert
the analysis, and choose amouse test gene anddefine a similar gene co-
expression neighbourhood in the mouse samples, and calculate the
average distance between the expression of orthologues of the test gene
and expression of neighbourhood genes across the human samples. The
average change in the human-to-mouse andmouse-to-human distances,
referred herein as a NACC score, is a symmetricmeasure of the degree
of conservation of co-expression for each gene. The distribution of this
quantity for each gene is shown in Fig. 2c, showing that genes in one
species show a strong tendency to be co-expressed with orthologues of
similarly expressed genes in the other species compared to randomgenes
(also see Supplementary Information).Wequantify thedegree towhich
a specific biological process diverges betweenhuman andmouse as the
average NACC scores of genes in each gene ontology category by cal-
culating a z-score using random sampling of equal size sets of genes.
Figure 2d shows that genes coding for proteins in the nuclear and intra-
cellularorganelle compartments, and involved inRNAprocessing,nucleic
acid metabolic processes, chromatin organization and other intracel-
lularmetabolic processes, tend to exhibitmore similar gene expression
patterns betweenhuman andmouse.On the other hand, genes involved
in extracellularmatrix, cellular adhesion, signalling receptors, immune
responses and other cell-membrane-related processes aremore diverged
(for a complete list of all GO categories and conservation analysis, see
Supplementary Table 21). As a control, when we applied the NACC
analysis to two different replicates of RNA-seq data sets from the same
species, nodifference inbiological processes canbedetected (Supplemen-
tary Fig. 5).
Several lines of evidence indicate that NACC is a sensitive and
robust method to detect conserved as well as diverged gene expression
patterns from a panel of imperfectlymatched tissue samples. First, when
we applied NACC to a set of simulated data sets, we found that NACC
is robust for the diversity and conservationof themouse–human sample
panel (in Supplementary Fig. 6). Second, we randomly sampled sub-
sets of the full panel of samples anddemonstrated that the categories of
human–mouse divergence shown in Fig. 2d are robust to the particu-
lar sets of samples we selected (Supplementary Fig. 7). Third, when we
repeatedNACCon a limited collection ofmore closelymatched tissues
and primary cell types (see SupplementaryMethods), the biological pro-
cesses detected as conserved and species-specific in the larger panel of
mismatchedhuman–mouse samples are largely recapitulated, although
some pathways are detected with somewhat less significance, probably
owing to the smaller number of data sets used (Supplementary Fig. 8).
In summary, the NACC results support and extend the principal com-
ponent analysis, showing that while large differences between mouse
and human transcriptome profiles can be observed (revealed in PC1),
genes involved indistinct cellular pathways or functional groups exhibit
different degreesof conservationof expressionpatternsbetweenhuman
andmouse,with some strongly preserved andothers changingmarkedly.
Prevalent species-specific regulatory sequences along
with a core of conserved regulatory sequences
To better understand how divergence of cis-regulatory sequences is
linked to the range of conservation patterns detected in comparisons
of gene expressionprogramsbetween species,we examined evolutionary
patterns in our predicted regulatory sequences. Previous studies have
identifiedawide rangeof evolutionarypatternsandrates for cis-regulatory
regions inmammals5,8, but there are still questions regarding the over-
all degree of similarity and divergence between the cis-regulatory land-
scapes in the mouse and human. The variety of assays and breadth of
tissue and cell-type coverage in themouseENCODEdata thereforepro-
vide an opportunity to address this problem more comprehensively.
We first determined sequencehomologyof the predicted cis-elements
in themouse and human genomes.We established one-to-one and one-
to-manymapping of human andmouse bases derived from reciprocal
chained blastz alignments48 and identified conserved cis-regulatory
sequences49. This analysis showed that 79.3%of chromatin-based enhan-
cer predictions, 79.6% of chromatin-based promoter predictions, 67.1%
of the DHS, and 66.7% of the transcription factor binding sites in the
mouse genome have homologues in the human genome with at least
10%overlappingnucleotides, while by randomchance one expects 51.2%,
52.3%,44.3%and39.3%, respectively (Fig. 3a, Supplementary Information
for details). With a more stringent cutoff that requires 50% alignment
of nucleotides, we found that 56.4%of the enhancer predictions, 62.4%
of promoter predictions, 61.5% of DHS, and 53.3% of the transcrip-
tion factor binding sites have homologues, comparedwith an expected
frequency of 34%, 33.8%, 33.6% and 33.7% by random chance (Sup-
plementary Fig. 9). The candidatemouse regulatory regionswith human
homologues are listed in Supplementary Tables 22–25. Thus, between
half and two-thirds of candidate regulatory regions demonstrate a sig-
nificant enrichment in sequence conservationbetweenhumanandmouse.
Theremaininghalf toone-thirdhaveno identifiableorthologous sequence.
The candidate regulatory regions in mouse with no orthologue in
humancould arise either because theywere generatedby lineage-specific
events, such as transposition, orbecause the orthologue in the other spe-
cieswas lost. Species-specific cis-regulatory sequences have been reported
before3,14, but the fractionof regulatory sequences in this category remains
debatable andmay vary with different roles in regulation.We find that
15% (12,387 out of 82,853) of candidate mouse promoters and 16.6%
(48,245 out of 291,200) of candidate enhancers (both predicted by pat-
terns of histonemodifications) haveno sequence orthologue in humans
(SupplementaryTables 26, 28, for details please refer to Supplementary
Methods section). However, the question remains as to whether these
species-specific elements are truly functional elements or simply corre-
spond to false-positive predictions due to measurement errors or bio-
logical noise. Supporting the function of mouse-specific cis elements,
18outof 20 randomly selected candidatemouse-specific promoters tested
positive using reporter assays inmouse embryonic stem cells, where they
were initially identified (Fig. 3b, Supplementary Table 27). Further, when
these 18mouse-specific promoters were tested using reporter assays in
the human embryonic stem cells, all of them also exhibited significant
promoter activities (Extended Data Fig. 2a, Supplementary Table 27),
indicating that themajority of candidatemouse-specific promoters are
indeed functional sequences,which are either gained in themouse lineage
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or lost in thehuman lineage. Similarly, amajority of the candidatemouse-
specific enhancers discovered in embryonic stem cells are also likely bona
fide cis elements, as 70.2% (26 out of 37) candidate enhancers randomly
selected from this group were found to exhibit enhancer activities in
reporter assays (Fig. 3b, Supplementary Table 29). Like the candidate
mouse-specific promoters, 61.5% (16out of 26) of the candidatemouse-
specific enhancers also show enhancer activities in human embryonic
stem cells (Extended Data Fig. 2a).
We next testedwhether the rapidly diverged cis-regulatory elements
would correspond to the same cellular pathways shown to be less con-
served by the NACC analysis of gene expression programs. Indeed,
gene ontology analysis revealed that the mouse-specific regulatory ele-
ments are significantly enriched near genes involved in immune func-
tion (Fig. 3c), in agreement with the divergent transcription patterns
for these genes reported earlier and a previous report based on a smaller
number of primate-specific candidate regulatory regions50. This sug-
gests that regulation of genes involved in immune function tends to be
species-specific50, just as the protein-coding sequences coding for immu-
nity, pheromones and other environmental genes are frequent targets
for adaptive selection in each species2,51. The target genes for mouse-
specific transcription factor binding sites (Supplementary Table 30) are
enriched inmolecular functions such as histone acetyltransferase activity
and high-density lipoprotein particle receptor activity, in addition to
immune function (IgG binding).
Wenext investigated themechanisms generatingmouse-specific cis-
regulatory sequences: loss in human, gain inmouse, or both. 89% (42,947
out of 48,245) of mouse-specific enhancers and 85% (10,535 out of
12,387) of mouse-specific promoters overlap with at least one class of
repeat elements (compared to 78% by random chance). Confirming
earlier reports52–54, we found thatmouse-specific candidate promoters
and enhancers are significantly enriched for repetitiveDNAsequences,
with several classes of repeat DNA highly represented (Fig. 3d and Ex-
tendedData Fig. 2b). Furthermore,mouse-specific transcription factor
binding sites are highly enriched inmobile elements such as short inter-
spersed elements (SINEs) and long terminal repeats (LTRs)55.
The 50% to 60% of candidate regulatory regions with sequences
conserved between mouse and human are a mixture of (1) sequences
whose function has been preserved via strong constraint since these
species diverged, (2) sequences that have been co-opted (or exapted)
to perform different functions in the other species, and (3) sequences
whose orthologue in the other species no longer has a discernable func-
tion, but divergence by evolutionary drift has not been sufficient to pre-
vent sequence alignmentbetweenmouse andhuman. Several companion
papers delve deeply into these issues22,23,49. In particular, ref. 23 shows that
the conservation of transcription factor binding at orthologous positions
(falling in category (1)) is associated with pleiotropic roles of enhancers,
as evidenced by activity in multiple tissues. References 22,49 describe
the exaptation of conserved regulatory sequences for other functions.
We surveyed the conservation of function in the subset of mouse
candidate cis elements that have sequence counterparts in the human
genome.Of the 51,661 chromatin-based promoter predictions that have
human orthologues, 44% (22,655) of them are still predicted as promo-
ters in human on the basis of the same analysis of histone modifications
(Supplementary Table 31, see SupplementaryMethods for details). Of
the 164,428 chromatin-based enhancer predictions that have human
orthologues, 40% (64,962) of them are predicted as an enhancer in
human (Supplementary Table 32). The remaining 56–60%of candidate
mouse regulatory regions with a human orthologue fall into category
(2) or (3) (see earlier), that is, the orthologous sequence in human either
performs a different function or does notmaintain a detectable function.
One caveat of the above observation is that the tissues or cell sam-
ples used in the survey were not perfectly matched. To better examine
the conservation of biochemical activities among these predicted cis-
regulatory elements with orthologues between mouse and human, we
analysed the chromatin modifications at the promoter or enhancer
predictions in a broad set of 23 mouse tissue and cell types with the
neighbourhood co-expression association analysis (NACC) method
described above. Instead of gene expression levels, we selected the his-
tone modification H3K27ac as an indicator of promoter or enhancer
activity as previously reported56. As shown inFig. 4a, the promoter pre-
dictions (blue) show a significantly higher correlation in the level of
H3K27ac in human and mouse than the random controls (red). Simi-
larly,most chromatin-based enhancer predictions in themouse genome
exhibit conserved chromatinmodification patterns in the human, albeit
to a lesser degree than thepromoters (Fig. 4b).NACCanalysis onDNase-
seq signal resulted in very similar distributions of conserved chromatin
accessibility patterns at promoters (Fig. 4c) and enhancers (Fig. 4d). Thus
many sequence-conserved candidate cis-regulatory elements appeared
to have conserved patterns of activities in mice and humans.
Taken together, these analyses show that themammalian cis-regulatory
landscapes in thehuman andmouse genomes are substantially different,
driven primarily by gain or loss of sequence elements during evolution.
These species-specific candidate regulatory elements are enriched near
genes involved in stress response, immunity and certainmetabolic pro-
cesses, and contain elevated levels of repeated DNA elements. On the
other hand, a core set of candidate regulatory sequences are conserved
and display similar activity profiles in humans and mice.
Chromatinstate landscapereflects tissueandcell identities
We examined gene-centred chromatin state maps in the mouse and
human cell types (see SupplementaryMethods) (Fig. 5a, Supplementary
Fig. 10). In all cell types, the low-expressed genes were almost uniformly
in chromatin states with the repressiveH3K27me3mark or in the state
unmarked by these histonemodifications. In contrast, expressed genes
showed the canonical pattern ofH3K4me3 at the transcription start site
surrounded byH3K4me1, followed byH3K36me3-dominated states in
the remainder of the transcription unit. A similar pattern was seen for
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Figure 3 | Comparative analysis of the cis-elements predicted in the human
and mouse genome. a, Chart shows the fractions of the predicted mouse
cis-regulatory elements with homologous sequences in the human genome
(Methods). TFBS, transcription factor binding site. b, A bar chart shows the
fraction of the DNA fragments tested positive in the reporter assays performed
either using mouse embryonic stem cells (mESCs) or mouse embryonic
fibroblasts (MEF). c, A chart shows the gene ontology (GO) categories enriched
near the predicted mouse-specific enhancers. d, A bar chart shows the
percentage of the predicted mouse-specific enhancers containing various
subclasses of LTR and SINE elements. As control, the predicted mouse cis
elements with homologous sequences in the human genome or random
genomic regions are included.
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all the active genes, regardless of the level of expression; the only excep-
tion was a tendency for the H3K4me3 to spread further into the tran-
scription unit for the most highly expressed genes. The same binary
relationship between chromatin statemaps and expression levels of genes
was observed in mouse and human cell types (Supplementary Fig. 10).
For bothmouse and human cells, themajority of the genomewas in
the unmarked state in each cell type, consistent with previous obser-
vations inDrosophila57 and human cell lines12 (Supplementary Fig. 2).
About 55% of the mouse genome was in an unmarked state in all the
15 cell types examined, while 65% is unmarked in all six human cell
types. For genes that were in the unmarked state inmouse, their ortho-
logues in human also tended to be in the unmarked state, and vice versa,
leading to a positive correlation for the amount of geneneighbourhoods
in unmarked states (Supplementary Fig. 11). Strong correlations were
also observed in profiles of other chromatin marks averaged over cell
lines and tissues37. The genes in the unmarked zones were depleted of
transcribed nucleotides relative to the number expected based on frac-
tion of the genome included, and the levels of the transcripts mapped
there were lower than those seen in the active chromatin states (Sup-
plementary Fig. 12).
Previous studies revealed limited changes of the chromatin states
in lineage-restricted cells as they undergo large-scale changes in gene
expression during maturation58–60. The chromatin state maps recapi-
tulated this result, showing very similar patterns of chromatin modi-
fication in a cell line model for proliferating erythroid progenitor cells
(G1E) and inmaturing erythroblasts (G1E-ER4 cells treated with oes-
tradiol) across geneswhose expression level changed significantlyduring
maturation (Fig. 5b, SupplementaryFig. 10b). This limited change raised
the possibility that the chromatin landscape, once established during
lineage commitment, dictates a permissive (or restrictive) environment
for the gene regulatory programs in each cell lineage60, and that the
chromatin states may differ between cell lineages. We tested this by
examining the chromatin state maps for genes that were differentially
expressed between haematopoietic cell lineages (erythroblasts versus
megakaryocytes), and we found marked differences between the two
cell types (Fig. 5c and Supplementary Fig. 10b). Genes expressed at a
higher level in megakaryocytes than in erythroblasts were all in active
chromatin states in megakaryocytes, but many were in inactive chro-
matin states in erythroblasts (Fig. 5c). In the converse situation, genes
expressedat ahigher level in erythroblasts than inmegakaryocytes showed
more inactive states in the cells inwhich theywere repressed (Supplemen-
tary Fig. 10b). These greater differences in chromatin states correlating
with differential expression of genes between, but not within, cell line-
ages support themodel that chromatin states are establishedduring the
process of lineage commitment. The clustering of cell types together by
lineage based on chromatin state maps (Supplementary Fig. 10c) also
supports the model that the landscape of active and repressed chro-
matin is established no later than lineage commitment, and that this
landscape is a defining feature of each cell type. Greater differences in
chromatin states correlating with differences in gene expression were
also observed when comparing average chromatin profiles in human
and mouse37.
Mouse chromatin states inform interpretation of human
disease-associated sequence variants
To investigate whether the mouse chromatin states were informative
on sequence variants linked to human diseases by genome-wide asso-
ciation studies (GWAS), we combined the chromatin state segmenta-
tions of the fifteen mouse samples into a refined segmentation, which
we used to train a self-organizingmap (SOM)61 on four histonemodi-
fication ChIP-seq data sets (H3K4me3, H3K4me1, H3K36me3 and
H3K27me3) for each mouse sample. We mapped 4,265 single nucleo-
tide polymorphisms (SNPs) from the human GWAS studies uniquely
onto the mouse genome and scored these SNPs onto the trained SOM
todeterminewhether SNP subsetswere enriched in specific areas of the
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map. As shown in Fig. 6a, the highest enriched H3K4me1 unit in the
kidney contains five GWAS hits (P value, 3.953 10214) on different
chromosomes related to blood characteristics such as platelet counts
(Fig. 6a, ExtendedData Table 2a). Similarly, the second highest enriched
unit in liver H3K36me3 contained six GWAS hits (P value, 7.54
310231) related to cholesterol and alcohol dependence out of twelve in
that unit (Fig. 6b, ExtendedData Table 2b). In contrast, one of the highest
units in brainH3K27me3has fiveGWAShits (P value, 4.933 10233)
on different chromosomes associated with brain disorders/response
to addictive substances (Fig. 6c, Extended Data Table 2c). This unit is
different from the other examples in that it is enriched for H3K27me3
signal in multiple tissues, with brain being the highest. 801 out of the
1,350 units of the map showed statistical enrichment of SNPs of 0.05
after Holm–Bonferroni correction for multiple hypothesis testing,
55% of which (accounting for 1,750 GWAS hits) had signal for at least
one histone mark that ranked within the top 100 units on the map
(Fig. 6d). The best histone marks for enriched GWAS units were pri-
marilyH3K4me1 (23%),H3K36me3 (18%) andH3K27me3 (12%),with
H3K4me3 accounting for less than 2% of the remainder. Together these
results suggest that the chromatin state maps can be used to identify
potential sites for functional characterization inmouse for humanGWAS
hits. Indeed, ref. 23 shows that conserved DNA segments bound by
orthologous transcription factors in human and mouse are enriched
for trait-associated SNPs mapped by GWAS.
Large-scale chromatin domains are developmentally
stable and evolutionarily conserved
We mapped the positions of early and late replication timing bound-
aries in each of 36mouse and 31 human profiles (Fig. 7a). Significantly
clustered boundary positions (above the 95th percentile of re-sampled
positions) were identified and peaks in boundary density were aligned
between cell types using a commonheuristic (ExtendedData Fig. 3a, b,
Supplementary Fig. 13). After alignment, consensus boundaries were
further classified by orientation and amount of replication timing sepa-
ration, resulting in amore stringent filtering of boundaries (Supplemen-
taryFigs 14, 15).Overall,we found that88%ofboundarypositions (versus
20% expected for random alignment; Fisher exact test P, 23 10216)
alignedposition and orientation between twoormore cell types in both
mouse andhuman (that is, 12%werecell-type-specific, Fig. 7b, Extended
Data Fig. 3). Pair-wise comparisons of boundarieswere consistentwith
developmental similarity between cell types (Supplementary Fig. 16).
The earliest and latest replicating boundaries weremost well preserved
between cell types, while those of mid-S replicating boundaries were
highly variable (Extended Data Fig. 3e, f).
Interestingly, the greatest number of boundaries was detected in
embryonic stemcells inboth species,with significant reduction inbound-
ary numbers during differentiation (Supplementary Fig. 16), consistent
with consolidation of domains and by proxy large-scale chromatin orga-
nization into larger ‘constant timing regions’ during differentiation62.
Given that over half of the mouse and human genomes exhibit signifi-
cant replication timing changes during development16,63, these obser-
vations support the model that developmental plasticity in replication
timing is derived from differential regulation of replication timing
within constant timing regions whose boundaries are preserved during
development.
Although conservation of replication timing between mouse and
human has been reported29,30, the conservation of replicating timing
boundaries has not been examined. We converted boundary coordi-
nates6 100 kb across boundary positions between species, revealing
significant overlap (Fig. 7c, d; P, 2.23 10216 by Fisher’s exact test
relative to a randomized boundary list). The level of conservation of
the positions of boundaries improved from a median of 27% for cell-
type-specific boundaries to 70% for boundaries preserved in nine or
more cell types (Fig. 7c), demonstrating that boundaries most highly
preserved during development were the most conserved across spe-
cies. This was consistent with results for transcription (Fig. 2), as well
as the previous observation that suggests that an increased plasticity of
replication timing during development is associatedwith increased plas-
ticity of replication timing during evolution64. Together, these findings
identify evolutionarily labile versus constrained domains of the mam-
malian genome at the megabase scale.
Given the linkbetween replication and chromatin assembly,we com-
pared replication timing and levels of other chromatin properties in
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200-kb windows across the genome (Supplementary Fig. 17). Features
associatedwith active enhancers (H3K4me1,H3K27ac,DNase I sensi-
tivity) weremore closely correlated to replication timing than features
associated with active transcription (RNA polymerase II, H3K4me3,
H3K36me3, H3K79me2). By contrast, the correlation of replication
timing to repressive features, such asH3K9me3,was poor and cell-type-
specific, consistent with prior results. A more stringent comparison of
differences in chromatin to differences in replication timing between
cell types (ExtendedData Fig. 3c, g, Supplementary Fig. 17) again revealed
thatmarks of enhancers, including p300,H3K4me1 andH3K27ac, and
DNase I sensitivity weremore strongly correlated to replication timing
than marks of active transcription.
Conclusion
By comparing the transcriptional activities, chromatin accessibilities,
transcription factor binding, chromatin landscapes and replication tim-
ing throughout themouse genome in awide spectrumof tissues and cell
types, we have made significant progress towards a comprehensive
catalogue of potential functional elements in the mouse genome. The
catalogue described in the current study should provide a valuable ref-
erence to guide researchers to formulate new hypotheses and develop
new mouse models, in the same way as the recent human ENCODE
studies have impacted the research community12.
We providemultiple lines of evidence that gene expression and their
underlying regulatoryprogramshave substantially diverged between the
human and mouse lineages although a subset of core regulatory pro-
grams are largely conserved. The divergence of regulatory programs
betweenmouse and human ismanifested not only in the gain or loss of
cis-regulatory sequences in the mouse genome, but also in the lack of
conservation in regulatory activities across different tissues and cell types.
This finding is in line with previous observations of rapidly evolving
transcription factor binding inmammals, flies and yeasts, and highlights
the dynamic nature of gene regulatory programs in different species3,4,7,65.
Furthermore, by comprehensivelydelineating thepotential cis-regulatory
elementswedemonstrated that specific groups of genes and regulatory
elements have undergone more rapid evolution than others. Of parti-
cular interest is the finding that cis-regulatory sequencesnext to immune-
system-related genes are more divergent. The finding of species-specific
cis-elements near genes involved in immune function suggests rapid
evolution of regulatory mechanisms related to the immune system.
Indeed, previous studies have uncovered extensive differences in the
immune systems among differentmouse strains and between humans
and mice66, ranging from relative makeup of the innate immune and
adaptive immune cells66, to gene expressionpatterns in various immune
cell types67, and transcriptional responses toacute inflammatory insults68,69.
At least some of these differences may be attributed to distinct regu-
latory mechanisms67, and our finding that many predicted mouse cis
elements near geneswith immune function lack sequence conservation
supports the model that evolution of cis-regulatory sequences contri-
butes to differences in the immune systems between humans andmice.
More generally, our findings are consistent with the view that changes
in transcriptional regulatory sequences are a source for phenotypic dif-
ferences in species evolution.
Howcanspecies-specific gainsor lossof cis-regulatory elementsduring
evolution be compatible with their putative regulatory function? The
finding of different rates of divergence associated with regulatory pro-
grams of distinct biological pathways suggests complex forces driving
the evolution of the cis-regulatory landscape in mammals. We discov-
ered that specific classes of endogenous retroviral elements are enriched
at the species-specific putative cis-regulatory elements, implicating trans-
position of DNA as a potentialmechanism leading to divergence of gene
regulatory programs during evolution. Previous studies have shown that
endogenous retroviral elements can be transcribed in a tissue-specific
manner70,71, with a fraction of themderived from enhancers and neces-
sary for transcriptionof genes involved inpluripotency72,73. Future studies
will be necessary to determine whether retroviral elements at or near
enhancers are generally involved in driving tissue-specific gene expres-
sion programs in different mammalian species.
Despite thedivergence of the regulatory landscapebetweenmouse and
human, thepatternof chromatin states (definedbyhistonemodifications)
and the large-scale chromatin domains are highly similar between the
two species. Half of the genome is well conserved in replication timing
(and by proxy, chromatin interaction compartment) with the other
half highly plastic both between cell types and between species. It will
be interesting to investigate the significance of these conserved and
divergent classes ofDNA elements at different scales, bothwith regard
to the forces driving evolution and for implications of the use of the
laboratory mouse as a model for human disease.
Online ContentMethods, along with any additional Extended Data display items
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Extended Data Figure 1 | Clustering analysis of human and mouse tissue
samples. a, RNA-seq data from Ilumina Body Map (adipose, adrenal, brain,
colon, heart, kidney, liver, lung, ovary and testis) were analysed together with
that from the matched mouse samples using clustering analysis. Genes with
high variance across tissues were used, resulting in cell samples clustering by
tissues, not by species. b, Clustering employing genes with high variance
between species shows clustering by species instead of tissues. c, Principal
Component Analysis (PCA) was performed for RNA-seq data for 10 human
andmousematching tissues. The expression values are normalized within each
species and we observed the clustering of samples by tissue types.
ARTICLE RESEARCH
Macmillan Publishers Limited. All rights reserved©2014
Extended Data Figure 2 | Comparative analysis of sequence conservation
in the cis elements predicted in the human and mouse genome. a, The
predicted mouse-specific promoters and enhancers can function in human
embryonic stem cells (hESCs). Percentages of predicted enhancers or
promoters that test positive are shown in a bar chart. b, A bar chart shows
the percentage of the predicted mouse-specific promoters containing various
subclasses of LTR and SINE elements. As control, the predicted mouse cis
elements with homologous sequences in the human genome or random
genomic regions are included.
RESEARCH ARTICLE
Macmillan Publishers Limited. All rights reserved©2014
Extended Data Figure 3 | Replication timing boundaries preserved among
tissues are conserved during evolution. a, Heat map of TTR overlap with
positive (yellow) or negative (blue) slope. Replication timing (RT) boundaries
were identified as clustered TTR endpoints (grey) above the 95th percentile
(dashed line) of randomly resampled positions (black). b, Examples of
constitutive boundaries (blue regions) and regulated boundaries (grey regions)
highlighted. c, Spearman correlations between differences in chromatin feature
enrichment and differences in RT in non-overlapping 200-kb windows.
d, Percentage of boundaries preserved between the indicated number of human
cell types. e, f, Distribution of boundary replication timing in mouse (e) and
human (f) as a function of preservation level between cell types. g, Comparison
of changes in replication timing versus various histone marks across a segment
of mouse chromosome 6.
ARTICLE RESEARCH
Macmillan Publishers Limited. All rights reserved©2014
Extended Data Table 1 | A seven-state chromHMM model learned from four histone modifications in 15 mouse cell types or lines and six
human cell lines is shown
State Feature H3K27m3 H3K4m3 H3K4m1 H3K36m3 Average% Variaon
1 K4m3 0.07 0.92 0.05 0.03 0.75 0.07
2 K4m1/3 0.17 0.85 0.88 0.05 0.55 0.10
3 K4m1 0.01 0.01 0.47 0.02 3.35 0.57
4 K4m1+K36m3 0.01 0.05 0.59 0.71 0.58 0.23
5 K36m3 0.00 0.00 0.01 0.42 6.31 1.54
6 Unmarked 0.01 0.00 0.00 0.00 85.45 9.20
7 K27m3 0.29 0.00 0.02 0.00 3.01 3.87
The numbers represent the emission probabilities of each histonemodification (column) in each chromatin state (row). The enriched histonemodifications in each state are summarized in the first column. The
fraction of genome assigned in each state was calculated (Supplementary Fig. 2). The average and variation of these fraction values across all included cell types/tissues are listed in the last two columns.
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Extended Data Table 2 | Self-organizing map of histone modifications shows enrichment of human GWAS SNPs when mapped onto mouse
a, Kidney-specific H3K4me1 that shows enrichment of specific GWAS hits associated with urate levels and metabolites. b, Liver-specific H3K36me3 unit shows enrichment in GWAS hits related to cholesterol,
alcohol dependence and triglyceride levels. c, Brain-specific H3K27me3 signals show enrichment in GWAS SNPs associated with neurological disorders.
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